$MGHL
MORGAN GROUP HOLDING CO

2021 Form 10-K Financial Statement

#000114036122012435 Filed on April 01, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $2.974M $801.1K $4.436M
YoY Change -32.96% -91.34% -52.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.350M $848.8K $4.501M
YoY Change -25.57% -91.09% -53.1%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.21K $2.470K $11.38K
YoY Change -1.5% 0.01%
% of Gross Profit
Operating Expenses $4.544M $1.249M $6.069M
YoY Change -25.13% -89.22% -47.92%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.570M -$447.8K -$1.633M
YoY Change -3.87% -80.87% -32.15%
Income Tax $723.00 $125.2K -$203.4K
% Of Pretax Income
Net Earnings -$1.571M -$573.0K -$1.430M
YoY Change 9.86% -68.87% -25.0%
Net Earnings / Revenue -52.83% -71.53% -32.24%
Basic Earnings Per Share -$2.62 -$2.38
Diluted Earnings Per Share -$2.62 -$954.9K -$2.38
COMMON SHARES
Basic Shares Outstanding 600.1K 600.1K 600.1K
Diluted Shares Outstanding 600.1K 600.1K

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.889M $4.746M $4.746M
YoY Change -39.13% -27.94% -27.94%
Cash & Equivalents $2.889M $4.746M $4.746M
Short-Term Investments
Other Short-Term Assets $350.0K $200.0K $200.0K
YoY Change 75.0% 0.0% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.622M $5.349M $5.349M
YoY Change -32.29% -31.52% -31.52%
LONG-TERM ASSETS
Property, Plant & Equipment $22.70K $33.92K $33.92K
YoY Change -33.08% -23.71% -23.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $679.5K $220.8K $220.8K
YoY Change 207.75% -21.67% -21.67%
Total Long-Term Assets $702.2K $254.7K $254.7K
YoY Change 175.69% -21.95% -21.95%
TOTAL ASSETS
Total Short-Term Assets $3.622M $5.349M $5.349M
Total Long-Term Assets $702.2K $254.7K $254.7K
Total Assets $4.324M $5.604M $5.604M
YoY Change -22.84% -31.14% -31.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $764.5K $464.6K $464.6K
YoY Change 64.57% 32.37% 32.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $812.9K $540.8K $540.8K
YoY Change 50.32% -61.1% -61.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $474.7K $455.5K $455.5K
YoY Change 4.22% -35.82% -35.82%
Total Long-Term Liabilities $474.7K $455.5K $455.5K
YoY Change 4.22% -35.82% -35.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $812.9K $540.8K $540.8K
Total Long-Term Liabilities $474.7K $455.5K $455.5K
Total Liabilities $1.288M $996.3K $996.3K
YoY Change 29.25% -52.55% -52.55%
SHAREHOLDERS EQUITY
Retained Earnings -$49.28M
YoY Change 2.99%
Common Stock $6.001K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.036M $4.607M $4.607M
YoY Change
Total Liabilities & Shareholders Equity $4.324M $5.604M $5.604M
YoY Change -22.84% -31.14% -31.14%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$1.571M -$573.0K -$1.430M
YoY Change 9.86% -68.87% -25.0%
Depreciation, Depletion And Amortization $11.21K $2.470K $11.38K
YoY Change -1.5% 0.01%
Cash From Operating Activities -$1.708M -$662.4K -$1.840M
YoY Change -7.19% -71.44% -22.35%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$840.00 $842.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$840.00 -$842.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -1.708M -662.4K -1.840M
Cash From Investing Activities 0.000 -840.0 -842.0
Cash From Financing Activities 0.000 0.000
Net Change In Cash -1.708M -663.2K -1.841M
YoY Change -7.24% -85.87% -61.2%
FREE CASH FLOW
Cash From Operating Activities -$1.708M -$662.4K -$1.840M
Capital Expenditures $0.00 -$840.00 $842.00
Free Cash Flow -$1.708M -$661.5K -$1.841M
YoY Change -7.24% -71.47% -22.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001162283
CY2021 dei Security Exchange Name
SecurityExchangeName
NONE
CY2021 dei Auditor Firm
AuditorFirmId
49
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
333-73996
CY2021 dei Entity Registrant Name
EntityRegistrantName
Morgan Group Holding Co
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-4196940
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
401 Theodore Fremd Avenue
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Rye
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10580
CY2021 dei City Area Code
CityAreaCode
914
CY2021 dei Local Phone Number
LocalPhoneNumber
921-5216
CY2021 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.01 per share
CY2021 dei Trading Symbol
TradingSymbol
MGHL
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
206725
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
600090
CY2021 dei Auditor Name
AuditorName
RSM US, LLP
CY2021 dei Auditor Location
AuditorLocation
New York, New York
CY2021 mghl Sales Manager Fees
SalesManagerFees
0
CY2020 mghl Sales Manager Fees
SalesManagerFees
334825
CY2021Q4 mghl Deferred Income Tax Assets Net Of Valuation Allowances And Deferred Tax Liability
DeferredIncomeTaxAssetsNetOfValuationAllowancesAndDeferredTaxLiability
0
CY2020Q4 mghl Deferred Income Tax Assets Net Of Valuation Allowances And Deferred Tax Liability
DeferredIncomeTaxAssetsNetOfValuationAllowancesAndDeferredTaxLiability
2930
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
46
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
29376
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
764512
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
464554
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2930
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
842
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-842
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1707506
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1840694
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4946403
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6787097
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3238897
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4946403
CY2021 mghl Income Taxes Received From Parent
IncomeTaxesReceivedFromParent
0
CY2020 mghl Income Taxes Received From Parent
IncomeTaxesReceivedFromParent
107158
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2888897
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4746403
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
350000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
200000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3238897
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4946403
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
17746
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align: justify; color: #000000; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that reporting period.  Actual results could differ from those estimates.</div>
CY2021 mghl Underwriter Payment Receiving Maximum Period
UnderwriterPaymentReceivingMaximumPeriod
P90D
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2952697
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4356311
CY2021 mghl Increase Decrease In Defined Contribution Plan Employer Discretionary Contribution Amount
IncreaseDecreaseInDefinedContributionPlanEmployerDiscretionaryContributionAmount
-10295
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-186217
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2572
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
723
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-20159
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
361
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
723
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-203443
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0510
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0312
CY2021 mghl Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percentage
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercentage
-0.0514
CY2020 mghl Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percentage
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercentage
-0.0217
CY2021 mghl Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percentage
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercentage
-0.2120
CY2020 mghl Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percentage
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercentage
-0.0829
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0019
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0123
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0005
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1243
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
779104
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
337606
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
0
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
0
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
13640
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
29650
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
792744
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
367256
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
789809
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
354833
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2935
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12423
CY2021Q4 mghl Deferred Tax Liabilities Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxLiabilitiesDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2935
CY2020Q4 mghl Deferred Tax Liabilities Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxLiabilitiesDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9468
CY2021Q4 mghl Deferred Tax Liabilities Deferred State Income Tax
DeferredTaxLiabilitiesDeferredStateIncomeTax
0
CY2020Q4 mghl Deferred Tax Liabilities Deferred State Income Tax
DeferredTaxLiabilitiesDeferredStateIncomeTax
2955
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2935
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
12423
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
789809
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
354833
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
275285
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
48350
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1571060
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1430036
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.62
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1571060
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1430036
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.62
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.38
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60009005
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
600090
CY2020Q2 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
600090
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
600090

Files In Submission

Name View Source Status
0001140361-22-012435-index-headers.html Edgar Link pending
0001140361-22-012435-index.html Edgar Link pending
0001140361-22-012435.txt Edgar Link pending
0001140361-22-012435-xbrl.zip Edgar Link pending
brhc10035820_10k.htm Edgar Link pending
brhc10035820_10k_htm.xml Edgar Link completed
brhc10035820_ex21-1.htm Edgar Link pending
brhc10035820_ex31-1.htm Edgar Link pending
brhc10035820_ex31-2.htm Edgar Link pending
brhc10035820_ex32-1.htm Edgar Link pending
brhc10035820_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mghl-20211231.xsd Edgar Link pending
mghl-20211231_cal.xml Edgar Link unprocessable
mghl-20211231_def.xml Edgar Link unprocessable
mghl-20211231_lab.xml Edgar Link unprocessable
mghl-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending